Morphological and behavioral responses of zebrafish after 24 h of ketamine embryonic exposure
Creators
- 1. Laboratory Animal Science (LAS), Institute for Molecular and Cell Biology (IBMC), University of Porto - UP, Porto (Portugal)
- 2. Institute for Research and Innovation in Health (i3S), University of Porto (UP), Porto (Portugal)
- 3. Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real (Portugal)
- 4. Life Sciences and Environment School (ECVA), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real (Portugal)
- 5. School of Agrarian and Veterinary Sciences (ECAV), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real (Portugal)
Description
Ketamine, one anesthetic used as an illicit drug, has been detected both in freshwater and marine ecosystems. However, knowledge of its impact on aquatic life is still limited. This study aimed to test its effects in zebrafish embryos by analyzing its time- and dose-dependent developmental toxicity and long-term behavioral changes. The 24 h-LC50 was calculated from percent survival using probit analysis. Based on the 24 h-LC50 (94.4 mg L−1), embryos (2 hour post-fertilization - hpf) were divided into four groups, including control, and exposed for 24 h to ketamine concentrations of 50, 70 or 90 mg L−1. Developmental parameters were evaluated on the course of the experimental period, and anatomical abnormalities and locomotor deficits were analyzed at 144 hpf. Although the portion of ketamine transferred into the embryo was higher in the lowest exposed group (about 0.056 ± 0.020 pmol per embryo), the results showed that endpoints such as increased mortality, edema, heart rate alterations, malformation and abnormal growth rates were significantly affected. At 144 hpf, the developmental abnormalities included thoracic and trunk abnormalities in the groups exposed to 70 and 90 mg L−1. Defects in cartilage (alcian blue) and bone (calcein) elements also corroborated the craniofacial anomalies observed. A significant up-regulation of the development-related gene nog3 was detected by qRT-PCR at 8 hpf. Early exposure to ketamine also resulted in long-term behavioral changes, such as an increase in thigmotaxis and disruption of avoidance behavior at 144 hpf. Altogether, this study provides new evidence on the ketamine teratogenic potential, indicating a possible pharmacological impact of ketamine in aquatic environments. - Highlights: • 24 h exposure to ketamine increases mortality. • Morphological changes were observed after exposure. • Exposure to ketamine leads to severe craniofacial anomalies. • Developmental gene expression changes in response to ketamine. • Developmental ketamine exposure produces lasting behavioral changes.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.taap.2017.02.013Additional details
Identifiers
- DOI
- 10.1016/j.taap.2017.02.013;
- PII
- S0041-008X(17)30080-7;
Publishing Information
- Journal Title
- Toxicology and Applied Pharmacology
- Journal Volume
- 321
- Journal Page Range
- p. 27-36
- ISSN
- 0041-008X
- CODEN
- TXAPA9
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 49040442
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- ANESTHETICS; AQUATIC ECOSYSTEMS; CARTILAGE; CONCENTRATION RATIO; EDEMA; EMBRYOS; FERTILIZATION; FRESH WATER; GENES; HEART; LARVAE; MALFORMATIONS; MORTALITY; PLANT GROWTH; POLYMERASE CHAIN REACTION; SKELETON; TOXICITY
- Descriptors DEC
- ANIMAL TISSUES; BODY; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM AGENTS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CONNECTIVE TISSUE; DIMENSIONLESS NUMBERS; DRUGS; ECOSYSTEMS; GENE AMPLIFICATION; GROWTH; HYDROGEN COMPOUNDS; ORGANS; OXYGEN COMPOUNDS; PATHOLOGICAL CHANGES; SYMPTOMS; WATER
Optional Information
- Copyright
- Copyright (c) 2017 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.